What are molecular subtypes of basal carcinoma?

• Molecular signatures may help defining subsets of “responders”, while sparing other patients (p53-like tumors) from unnecessary therapy related toxicity, and delay of cystectomy. • Find potential therapeutic targets • No published recommendation concerning routine use of molecular profiling